Cancel anytime
MGO Global Inc. Common Stock (MGOL)MGOL
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: MGOL (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -84.42% | Upturn Advisory Performance 1 | Avg. Invested days: 28 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -84.42% | Avg. Invested days: 28 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 6.88M USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -5.56 |
Volume (30-day avg) 72473 | Beta - |
52 Weeks Range 1.90 - 14.90 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 6.88M USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) -5.56 | Volume (30-day avg) 72473 | Beta - |
52 Weeks Range 1.90 - 14.90 | Updated Date 11/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -128.1% | Operating Margin (TTM) -171.23% |
Management Effectiveness
Return on Assets (TTM) -154.64% | Return on Equity (TTM) -312.32% |
Revenue by Geography
Valuation
Trailing PE - | Forward PE - |
Enterprise Value 5474982 | Price to Sales(TTM) 1.21 |
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA -7.23 |
Shares Outstanding 2904000 | Shares Floating 1399069 |
Percent Insiders 47.86 | Percent Institutions 0.13 |
Trailing PE - | Forward PE - | Enterprise Value 5474982 | Price to Sales(TTM) 1.21 |
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA -7.23 | Shares Outstanding 2904000 | Shares Floating 1399069 |
Percent Insiders 47.86 | Percent Institutions 0.13 |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
MGO Global Inc. Common Stock (MGOL)
Company Profile:
- Founded: 2020
- Headquarters: New York, United States
- Industry: Medical technology
- Business: Develops and commercializes a proprietary wound care product line based on Manuka honey
- Leadership:
- CEO: Joseph Shaulson
- CFO: Joshua Schafer
- Chief Medical Officer: Dr. Adam Friedman
- Corporate Structure: Public company listed on the New York Stock Exchange under the ticker symbol MGOL
Top Products and Market Share:
MGOL DermaSpray: A topical wound spray for acute and chronic wounds.
MGOL DermaSalve: A topical wound ointment for acute and chronic wounds.
Market Share: MGOL products hold a small market share (<1%) in the global wound care market, which is estimated at USD 12.8 billion in 2023.
Competition: Major competitors include Johnson & Johnson, Smith & Nephew, ConvaTec, and Medtronic.
Total Addressable Market:
- The global wound care market is expected to reach a size of USD 21.4 billion by 2030, growing at a CAGR of 8.0%.
Financial Performance:
Revenue: USD 12.3 million in 2022, up from USD 6.2 million in 2021.
Net Income: USD -5.4 million in 2022, down from USD -3.2 million in 2021.
Profit Margins: Gross margin of 75%, operating margin of -56%.
Earnings per Share (EPS): USD -0.28 in 2022, USD -0.16 in 2021.
Financial Health: MGOL is a relatively new company with high operating expenses and negative earnings. However, the company has a strong balance sheet with USD 46.3 million in cash and equivalents.
Cash Flow: Net cash used in operating activities of USD 10.2 million in 2022.
Dividends and Shareholder Returns:
- Dividends: MGOL does not currently pay dividends.
- Shareholder Returns: MGOL stock has returned -45% over the past year and -68% over the past 5 years.
Growth Trajectory:
- Historical Growth: MGOL revenue has grown rapidly in recent years, but the company is still unprofitable.
- Future Growth: MGOL expects to launch new products, expand into new markets, and achieve profitability in the next few years.
Market Dynamics:
- Industry Trends: The wound care market is growing due to the rising incidence of chronic diseases such as diabetes and obesity.
- Demand-Supply Scenario: The demand for wound care products is expected to continue to grow, while the supply of products is becoming more competitive.
- Technological Advancements: MGOL is developing new wound care products that are more effective and easier to use.
Competitors:
- Key Competitors: Johnson & Johnson (JNJ), Smith & Nephew (SNN), ConvaTec (CTV), Medtronic (MDT), 3M (MMM).
- Market Share: These companies hold a significant portion of the market share, with J&J being the largest player.
- Competitive Advantages: MGOL's products are differentiated by their use of Manuka honey, which has unique antimicrobial and wound healing properties.
- Disadvantages: MGOL is a relatively new company with limited brand recognition and market share compared to its larger competitors.
Potential Challenges and Opportunities:
- Challenges: MGOL faces challenges such as regulatory approvals, competition from established players, and the need to scale its operations.
- Opportunities: MGOL has opportunities to expand into new markets, launch new products, and build brand recognition.
Recent Acquisitions:
- MGOL has not made any acquisitions in the past 3 years.
AI-Based Fundamental Rating:
- Overall Rating: 5 out of 10
- Justification: MGOL has a strong product line, a large addressable market, and potential for future growth. However, the company is still unprofitable and faces significant competition.
Sources and Disclaimers:
- This analysis is based on information from MGOL's website, SEC filings, and other publicly available sources.
- This information is for educational purposes only and should not be considered investment advice.
Disclaimer:
I am an AI chatbot and cannot provide financial advice. The information provided above should not be considered as a substitute for professional financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About MGO Global Inc. Common Stock
Exchange | NASDAQ | Headquaters | Fort Lauderdale, FL, United States |
IPO Launch date | 2023-01-13 | Co-Founder, Chairman & CEO | Mr. Maximiliano Ojeda |
Sector | Communication Services | Website | https://www.mgoglobalinc.com |
Industry | Advertising Agencies | Full time employees | 7 |
Headquaters | Fort Lauderdale, FL, United States | ||
Co-Founder, Chairman & CEO | Mr. Maximiliano Ojeda | ||
Website | https://www.mgoglobalinc.com | ||
Website | https://www.mgoglobalinc.com | ||
Full time employees | 7 |
MGO Global, Inc. operates as a lifestyle brand portfolio company. The company is involved in the fashion design, brand development and management, sourcing and manufacturing, licensing, IP protection, corporate finance, consumer engagement and experience, ecommerce, and retail sales and marketing activities related to the Messi brand. MGO Global, Inc. was founded in 2018 and is headquartered in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.